Failure of Treatment with First-Line Lopinavir Boosted with Ritonavir Can Be Explained by Novel Resistance Pathways with Protease Mutation 76V

M. Nijhuis, A.M.J. Wensing, W.F.W. Bierman, D. de Jong, R. Kagan, A. Fun, C.A.J.J. Jaspers, K.A.M. Schurink, M.A. van Agtmael, C.A.B. Boucher

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)698-709
JournalJournal of Infectious Diseases
Volume200
Issue number5
DOIs
Publication statusPublished - 2009

Cite this

Nijhuis, M., Wensing, A. M. J., Bierman, W. F. W., de Jong, D., Kagan, R., Fun, A., ... Boucher, C. A. B. (2009). Failure of Treatment with First-Line Lopinavir Boosted with Ritonavir Can Be Explained by Novel Resistance Pathways with Protease Mutation 76V. Journal of Infectious Diseases, 200(5), 698-709. https://doi.org/10.1086/605329